Cite
MLA Citation
J. Peron et al.. “2380 A new method to assess and test statistically the chance of a better outcome based on several endpoints in randomized trials, the case of erlotinib in metastatic pancreatic cancer.” European journal of cancer, vol. 51, n.d., pp. S463–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x00001b